Recent HIV infection among women and men enrolling to care in urban clinics in Ethiopia

埃塞俄比亚城市诊所登记就诊的男女近期感染艾滋病毒的情况

阅读:1

Abstract

BACKGROUND: Early HIV diagnosis allows timely interventions to control HIV transmission. We have determined the proportion of recent infections among people living with HIV (PLHIV) enrolling to care in Ethiopia and identified factors associated with recent infection. METHODS: Participants (aged ≥ 15 years) newly enrolled in HIV care were recruited from urban clinics in central Ethiopia (2022-2024). We used a recent infection testing algorithm, combining limiting antigen avidity serology and viral load quantification, to determine HIV infection recency. Factors associated with recent infection were investigated using logistic regression analysis, including sex-stratified analyses. RESULTS: Among 622 participants (median age 35 years; 364 [58.5%] women), 42 (6.8%) had recent infection. Recent infection was more common among PLHIV aged 15-24 years compared to those > 24 years (adjusted odds ratio [aOR], 4.3; 95% confidence interval [CI], 2.1-8.6), and in PLHIV belonging to key and priority populations (aOR, 2.2; 95% CI, 1.1-4.2). In sex-stratified analyses, age 15-24 years remained significantly associated with recent infection in both men (unadjusted odds ratio, 6.4; 95% CI, 1.5-26.5) and women (aOR, 2.7; 95% CI,1.2-6.1), whereas belonging to key and priority populations was significantly associated with recent infection only among women (aOR, 2.4; 95% CI, 1.1-5.2). CONCLUSION: A low proportion of PLHIV newly enrolled in care had recently acquired HIV infection. Recent infection was more common among persons aged 15-24 years and women belonging to key and priority populations. Further scale-up of HIV testing services are needed to improve detection of recent infection, which could help in prevention of new infections.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。